Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
出版年份 2021 全文链接
标题
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
作者
关键词
-
出版物
Lancet Respiratory Medicine
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-28
DOI
10.1016/s2213-2600(21)00139-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Anti-IL6 treatment of serious COVID-19 disease
- (2021) Laura Castelnovo et al. MEDICINE
- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- IL-6 blockade for COVID-19: a global scientific call to arms
- (2021) Srinivas Murthy et al. Lancet Respiratory Medicine
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- Interleukin-6: obstacles to targeting a complex cytokine in critical illness
- (2021) Oliver J McElvaney et al. Lancet Respiratory Medicine
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
- (2020) Tobias Herold et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis
- (2020) Jieyun Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Translating IL-6 biology into effective treatments
- (2020) Ernest H. Choy et al. Nature Reviews Rheumatology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
- (2020) Eddy Fan et al. Lancet Respiratory Medicine
- COVID-19 length of hospital stay: a systematic review and data synthesis
- (2020) Eleanor M. Rees et al. BMC Medicine
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preemptive interleukin-6 blockade in patients with COVID-19
- (2020) Lucía Guillén et al. Scientific Reports
- Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
- (2020) Shruti Gupta et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia
- (2020) Jonathan B. Parr JAMA Internal Medicine
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis
- (2020) Zheng Jie Lim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19
- (2020) Jose J. Guirao et al. MOLECULAR IMMUNOLOGY
- Cytokine Storm
- (2020) David C. Fajgenbaum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
- (2020) Lionel Piroth et al. Lancet Respiratory Medicine
- Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?
- (2020) Christopher J Yarnell et al. Lancet Respiratory Medicine
- Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect
- (2019) S.D. Walter et al. STATISTICS IN MEDICINE
- Defining standard of practice
- (2019) Federico Angriman et al. Current Opinion in Critical Care
- Interleukin-6: designing specific therapeutics for a complex cytokine
- (2018) Christoph Garbers et al. NATURE REVIEWS DRUG DISCOVERY
- Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
- (2016) Miguel A. Hernán et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Adaptive Designs for Clinical Trials
- (2016) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
- (2012) Monika M Schoels et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started